Primary pigmented nodular adrenocortical disease (PPNAD) as an underlying cause of symptoms in a patient presenting with hirsutism and secondary amenorrhea: case report and literature review

References

• Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing’s syndrome. Lancet. 2015;386:913–927.
   PubMed Web of Science ®Google Scholar
• Nieman LK. Cushing’s syndrome: update on signs, symptoms and biochemical screening. Eur J Endocrinol. 2015;173:M33–M38.
   PubMed Web of Science ®Google Scholar
• Lado-Abeal J, Rodriguez AJ, Newell PJD, et al. Menstrual abnormalities in women with Cushing’s disease are correlated with hypercortisolemia rather than raised circulating androgen levels. J Clin Endocrinol Metab. 1998;83:3083–3088.
   PubMed Web of Science ®Google Scholar
• Groussin L, Cazabat L, Rene-Corail F, et al. Adrenal pathophysiology: lessons from the Carney complex. Horm Res. 2005;64:132–139.
   PubMedGoogle Scholar
• Cieszyński Ł, Berendt-Obołończyk M, Szulc M, Sworczak K. Cushing’s syndrome due to ectopic ACTH secretion. Endokrynol Pol. 2016;67:458–471.
   PubMed Web of Science ®Google Scholar
• Cyranska-Chyrek E, Grzymislawska M, Ruchala M. Diagnostic pitfalls of adrenal incidentaloma. Endokrynol Pol. 2017;68:360–377.
   PubMed Web of Science ®Google Scholar
• Sikorska D, Bednarek-Papierska L, Mojs E, et al. Bilateral primary pigmented nodular adrenal disease as a component of Carney syndrome - case report. Endokrynol Pol. 2017;68:70–72.
   PubMed Web of Science ®Google Scholar
• Groussin L, Horvath A, Jullian E, et al. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J Clin Endocrinol Metab. 2006;91:1943–1949.
   PubMed Web of Science ®Google Scholar
• Groussin L, Jullian E, Perlemoine K, et al. Mutations of the PRKAR1A gene in Cushing’s syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab. 2002;87:4324–4329.
   PubMed Web of Science ®Google Scholar
• Guana R, Gesmundo R, Morino M, et al. Laparoscopic unilateral adrenalectomy in children for isolated primary pigmented nodular adrenocortical disease (PPNAD): case report and literature review. Eur J Pediatr Surg. 2010;20:273–275.
   PubMed Web of Science ®Google Scholar
• Katanic D, Kafka D, Zivojinov M, et al. Primary pigmented nodular adrenocortical disease: literature review and case report of a 6-year-old boy. J Pediatr Endocrinol Metab. 2017;30:603–609.
   PubMed Web of Science ®Google Scholar
• Leka S, Kousta E, Anyfandakis K, et al. Primary pigmented nodular adrenocortical disease: a case report in a 7-year-old girl. J Pediatr Endocrinol Metab. 2011;24:197–202.
   PubMed Web of Science ®Google Scholar
• McArthur RG, Bahn RC, Hayles AB. Primary adrenocortical nodular dysplasia as a cause of Cushing’s syndrome in infants and children. Mayo Clin Proc. 1982;57:58–63.
   PubMed Web of Science ®Google Scholar
• Patarakijvanich N, Kayasut K, Mitarnun W, et al. Primary pigmented nodular adrenocortical disease with synaptophysin immunoreactivity in two Thai children. J Med Assoc Thai. 2007;90:1208–1213.
   PubMedGoogle Scholar
• Chan LF, Storr HL, Grossman AB, Savage MO. Pediatric Cushing’s syndrome: clinical features, diagnosis, and treatment. Arq Bras Endocrinol Metab. 2007;51:1261–1271.
   PubMedGoogle Scholar
• Larsen JL, Cathey WJ, Odell WD. Primary adrenocortical nodular dysplasia, a distinct subtype of Cushing’s syndrome. Case report and review of the literature. Am J Med. 1986;80:976–984.
   PubMed Web of Science ®Google Scholar
• Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab. 2001;86:4041–4046.
   PubMed Web of Science ®Google Scholar
• Young WF Jr, Carney JA, Musa BU, et al. Familial Cushing’s syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later. N Engl J Med. 1989;321:1659–1664.
   PubMed Web of Science ®Google Scholar
• Bourdeau I, Lacroix A, Schurch W, et al. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. J Clin Endocrinol Metab. 2003;88:3931–3937.
   PubMed Web of Science ®Google Scholar
• Louiset E, Stratakis CA, Perraudin V, et al. The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits. J Clin Endocrinol Metab. 2009;94:2406–2413.
   PubMed Web of Science ®Google Scholar
• Stratakis CA, Sarlis N, Kirschner LS, et al. Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med. 1999;131:585–591.
   PubMed Web of Science ®Google Scholar
• Powell AC, Stratakis CA, Patronas NJ, et al. Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasia. Surgery. 2008;143:750–758.
   PubMed Web of Science ®Google Scholar
• Braithwaite SS, Collins S, Prinz RA, et al. Decreased dehydroepiandrosterone sulfate in pigmented nodular adrenal dysplasia. Clin Chem. 1989;35:2216–2219.
   PubMed Web of Science ®Google Scholar
• Hofland J, de Herder WW, Derks L, et al. Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing’s syndrome. Eur J Endocrinol. 2012;168:67–74.
   PubMed Web of Science ®Google Scholar
• Zografos GN, Pappa T, Avlonitis S, et al. Primary pigmented nodular adrenocortical disease presenting with a unilateral adrenocortical nodule treated with bilateral laparoscopic adrenalectomy: a case report. J Med Case Reports. 2010;4:230.
   PubMedGoogle Scholar
• Doppman JL, Travis WD, Nieman L, et al. Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. Radiology. 1989;172:415–420.
   PubMed Web of Science ®Google Scholar
• Lacroix A, Ndiaye N, Tremblay J, Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing’s syndrome. Endocr Rev. 2001;22:75–110.
   PubMed Web of Science ®Google Scholar
• Horvath A, Stratakis C. Primary pigmented nodular adrenocortical disease and Cushing’s syndrome. Arq Bras Endocrinol Metabol. 2007;51:1238–1244.
   PubMedGoogle Scholar
• Shenoy BV, Carpenter PC, Carney JA. Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. Am J Surg Pathol. 1984;8:335–344.
   PubMed Web of Science ®Google Scholar
• Gunther DF, Bourdeau I, Matyakhina L, et al. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab. 2004;89:3173–3182.
   PubMed Web of Science ®Google Scholar
• Almeida MQ, Stratakis CA. Carney complex and other conditions associated with micronodular adrenal hyperplasias. Best Pract Res Clin Endocrinol Metab. 2010;24:907–914.
   PubMed Web of Science ®Google Scholar
• Groussin L, Kirschner LS, Vincent-Dejean C, et al. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet. 2002;71:1433–1442.
   PubMed Web of Science ®Google Scholar
• Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet. 2000;26:89–92.
   PubMed Web of Science ®Google Scholar
• Horvath A, Boikos S, Giatzakis C, et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet. 2006;38:794–800.
   PubMed Web of Science ®Google Scholar
• Horvath A, Mericq V, Stratakis CA. Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. N Engl J Med. 2008;358:750–752.
   PubMed Web of Science ®Google Scholar
• Chute AL, Robinson GC, Donohue WL. Cushing’s syndrome in children. J Pediatr. 1949;34:20–39.
   PubMed Web of Science ®Google Scholar
• Korpaisarn S, Trachoo O, Panthan B, et al. A novel PRKAR1A mutation identified in a patient with isolated primary pigmented nodular adrenocortical disease. Case Rep Oncol. 2017;10:769–776.
   PubMed Web of Science ®Google Scholar
• Bertherat J, Horvath A, Groussin L, et al. Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab. 2009;94:2085–2091.
   PubMed Web of Science ®Google Scholar
• Poukoulidou T, Maiter D, Bertherat J, Beauloye V. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease. J Pediatr Endocrinol Metab. 2014;27:1005–1009.
   PubMed Web of Science ®Google Scholar
• Bonnet-Serrano F, Bertherat J. Genetics of tumors of the adrenal cortex. Endocr Relat Cancer. 2018;25:R131–R152.
   PubMed Web of Science ®Google Scholar